| Latest | F'cast | |
|---|---|---|
| Div Yield | 2.2% | |
| Div Cover | 2.2 | |
| Op Mrgn | 3.8% | |
| ROCE | n/a | 
| Latest | F'cast | |
|---|---|---|
| P/E | 21.1 | |
| PEG | n/a | |
| Pr/Revenue | 0.4 | |
| Pr/Book | 2.5 | 
| Latest | F'cast | |
|---|---|---|
| Revenue | 26.6% | |
| PBT | -4.4% | |
| EPS | -30.3% | |
| DPS | 13.8% | 
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield | 
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 160,401.00 | 10,868.00 | 2,317.00¢ | 9.0 | 0.1 | +71% | 4.00¢ | 0.0% | 
| 31-Dec-21 | 174,078.00 | 6,782.00 | 1,587.00¢ | 14.5 | n/a | -32% | 400.00¢ | 1.7% | 
| 31-Dec-22 | 180,516.00 | 8,353.00 | 2,166.00¢ | 15.3 | 0.4 | +36% | 448.00¢ | 1.4% | 
| 31-Dec-23 | 195,265.00 | 5,513.00 | 1,757.00¢ | 17.0 | n/a | -19% | 492.00¢ | 1.6% | 
| 31-Dec-24 | 247,121.00 | 5,269.00 | 1,225.00¢ | 22.5 | n/a | -30% | 560.00¢ | 2.0% | 
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield | 
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 265,959.59 | 9,686.76 | 2,961.62¢ | 8.7 | 0.1 | +142% | 668.00¢ | 0.0% | 
| 31-Dec-26 | 278,599.06 | 10,608.03 | 3,278.42¢ | 7.9 | 0.7 | +11% | 707.43¢ | 0.0% | 
| 31-Dec-27 | 295,147.28 | 11,585.64 | 3,696.39¢ | 7.0 | 0.5 | +13% | 737.83¢ | 0.0% | 
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| US health insurer Cigna to buy Express Scripts i... | 08-Mar-2018 | ShareCast | 
| Cigna-Anthem merger blocked by federal judge in US | 09-Feb-2017 | ShareCast | 
| Cigna to share how its ranks doctors | 30-Oct-2007 | USA Today | 
| Cigna Profit Slips on Enrollment Decline | 02-Aug-2007 | New York Times | 
| Cigna targets small firms, individuals | 27-Nov-2006 | Chicago Tribune | 
| Currency | US Dollars | 
| Share Price | $ 258.62 | 
| Change Today | $ 14.21 | 
| % Change | 5.81 % | 
| 52 Week High | $343.06 | 
| 52 Week Low | $239.51 | 
| Volume | 2,095 | 
| Shares Issued | 402.51m | 
| Market Cap | $104,098m | 
| Beta | 0.18 | 
| RiskGrade | 166 | 
| Strong Buy | 9 | 
| Buy | 10 | 
| Neutral | 6 | 
| Sell | 0 | 
| Strong Sell | 0 | 
| Total | 25 | 

You are here: research